Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

742MO Neoadjuvant immune checkpoint blockade in mismatch repair deficient endometrial cancer

Autor: de Bruyn, M., Eerkens, A.L., Brummel, K., Vledder, A., Paijens, S.T., Requesens, M., Loiero, D., van Rooij, N., Plat, A., Klok, P., Haan, F-J., Church, D.N., Wardenaar, R., Foijer, F., Koelzer, V.H., Bosse, T., Bart, J., Jalving, M., Reyners, A.K.L., Nijman, H.W.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S508-S509

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.

Autor: Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. n.horeweg@lumc.nl., Workel HH; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands., Loiero D; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Church DN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Vermij L; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Léon-Castillo A; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Krog RT; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department Surgery, Leiden University Medical Center, Leiden, the Netherlands., de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nout RA; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Powell ME; Department of Clinical Oncology, Barts Health NHS Trust, London, United Kingdom., Mileshkin LR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., MacKay H; Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Singh N; Department of Pathology, Barts Health NHS Trust, London, United Kingdom., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Oncology and Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Nijman HW; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Bruyn M; Department of Gynaecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands.

Publikováno v: Nature communications [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1373. Date of Electronic Publication: 2022 Mar 16.